Flat Footed Demands Grifols Board Reformation to Safeguard Shareholders' Interests

In a recent turn of events, Flat Footed has put significant pressure on Grifols, a leading global producer of medicine derived from blood plasma, urging the company to overhaul its board of directors. This move comes in the wake of growing concerns about the firm's governance and its long-term commitment to protecting shareholder value.

Continue reading